运动可以将瘤从冷转变为热,并提高免疫疗法反应能力
Brindley Hapuarachi1,2, Sarah Danson1,2, Jon Wadsley2
1University Sheffield, Division of Clinical Medicine, Sheffield, United Kingdom.
Frontiers in immunology
|December 27, 2023
概括
定期炼可以改善癌症的结果,并通过转化免疫疗法来提高免疫疗法的有效性.
科学领域:
- 瘤学和运动科学
- 免疫学和癌症生物学
背景情况:
- 运动为癌症患者提供了显著的健康益处,改善了生存率和生活质量.
- 在临床前模型中,有氧和抵抗训练都显示出抗瘤特性.
- 运动会影响瘤微环境和全身免疫力,可能增强癌细胞的识别和破坏.
研究的目的:
- 审查运动和癌症之间的复杂相互作用.
- 探索运动在调节瘤微环境和系统免疫力中的作用.
- 研究运动在改善癌症免疫治疗反应方面的潜力.
主要方法:
- 对前临床小鼠癌症模型和临床研究的综述.
- 对淋巴细胞群,肌动因和细胞动因运动诱导的变化进行分析.
- 检查瘤微环境特征 ("热"与"冷"瘤).
主要成果:
- 运动促进免疫细胞的释放,调节瘤血管结构.
- 临床前数据表明,运动可以将"冷"瘤转化为"热"瘤.
- 一个"热"的瘤微环境可能会提高免疫治疗的响应能力.
结论:
- 运动有可能将冷瘤重新编程为热瘤,改善免疫治疗结果.
- 需要进行翻译性研究,以验证运动在增强癌症患者免疫治疗中的作用.
- 运动可能会扩大从免疫疗法中受益的瘤范围.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923


